Summary:
Segal Trials is currently enrolling in a clinical research study to evaluate a new investigational medicine for the acute treatment of migraines.
Qualified Participants Must:
Are 18 to 65 years of age
Have had migraines for at least 1 year
Have 2 to 8 migraine attacks each month
Have less than 15 headache days each month
Qualified Participants May Receive:
All study-related care will be provided at no cost, and participants may be compensated. Health insurance is not needed.